Chembio Diagnostics, Inc. Banner Image

Chembio Diagnostics, Inc.

  • Ticker CEMI
    Exchange NASDAQ More
  • Industry Diagnostic Substances More
  • Sector Healthcare More
Chembio Diagnostics, Inc. Logo Image
  • 51-200 Employees
  • Based in Medford, New York
Chembio Diagnostics, Inc. develops, manufactures, licenses and markets proprietary rapid diagnostic tests in the growing $8.0 billion point-of-care testing market. Chembio markets each of its DPP HIV 1/2 Assay, HIV 1/2 STAT-PAK Assay, and SURE CHECK HIV 1/2 Assay, with these Chembio brand names, in the U.S. and internationally both directly and through third-party distributors. The Company'sMore SURE CHECK HIV 1/2 Assay previously has been exclusively sold in the U.S. as Clearview Complete HIV 1/2 Assay.
4.8 / 5.0 (226)

Chembio Diagnostics, Inc. reports have an aggregate usefulness score of 4.8 based on 226 reviews.

Chembio Diagnostics, Inc.

Most Recent Annual Report

Chembio Diagnostics, Inc.
MOST RECENT 2022 Annual Report and Form 10K

Chembio Diagnostics, Inc. does not currently have any hardcopy reports on AnnualReports.com. Click the button below to request a report when hardcopies become available.

Request Information

Older/Archived Annual Reports

Chembio Diagnostics, Inc. Logo Image

Rate This Report

Your vote helps our reports be more useful
Rating Saved!

Thank you for your feedback!